Delivery Order SPE2DB20D3103-SPE2DB24FL5L6
Award Date
11/15/23
Potential Completion Date
11/16/23
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Emtricitabine-Tenofovir 200-300mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,633.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 29, 2024, with a completion date of October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,187.91, is a delivery order for the supply of emtricitabine-tenofovir 200-300 mg tablets. The contract has an ultimate completion date of February 18, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug emtricitabine-tenofovir 200-300 mg. The contract is a firm-fixed-price delivery order with a ceiling value of $9,138.74 and a period of performance through May 29, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This federal contract award is for the delivery of Emtricitabine-Tenofovir 200-300MG pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC, held by Amerisourcebergen's parent company Cencora, Inc., serves as the primary vehicle for the company to...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,949.47, is a delivery order for Emtricitabine-Tenofovir 200-300 mg medication in 30-count bottles. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,066.17 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg medication. The contract has an ultimate completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $4,177.73 firm fixed-price delivery order is for the supply of 4568123008 units of the pharmaceutical product Emtricitabine-Tenofovir 200-300mg. The contract has a performance period through May 5, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,923.81, is for the delivery of emtricitabine-tenofovir 200-300 mg prescription medications. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,752.24 firm fixed-price contract is for the supply of emtricitabine-tenofv 200-300mg tablets for a term ending on November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $1,223.20, is a Firm Fixed Price Delivery Order with a performance period through January 23, 2025. The award is for the supply of emtricitabine-tenofovir 200-300mg medication. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...